Arshed A. Quyyumi

Biography

Dr. Arshed A. Quyyumi has been involved in clinical translational research in cardiovascular diseases for over 25 years.  Dr. Quyyumi received his undergraduate degree in Pharmacology and medical degree  from the University of London, England. He completed his residency at Guy's and Royal Free Hospitals in London, and cardiology fellowships at National Heart Hospital, London; Massachusetts General Hospital, Boston; and the National Institutes of Health.   After completion of his residency and fellowship, he served in several capacities in the Cardiology Branch of National Heart Lung and Blood Institute, NIH in Bethesda, MD, including Senior Investigator and Director of the Cardiac Catheterization Laboratory.  In 2001 he was appointed Professor of Medicine in the Division of Cardiology at Emory University School of Medicine, and in 2010 he was named Co-Director of the Emory Clinical Cardiovascular Research Institute (ECCRI).  Since 2005, Dr. Quyyumi has been awarded more than $21 million in research funding.  He serves on the Editorial Boards of several national journals, is a member on several Scientific Advisory Boards, and is a reviewer for the NIH-NHLBI Study Sections.  Dr. Quyyumi has authored more than 180 peer-reviewed publications and has been an invited speaker and session chair at numerous National and International scientific meetings and conferences. Dr. Quyyumi's research focus includes vascular biology, angiogenesis, progenitor cell biology, mechanisms of myocardial ischemia, and the role of genetic and environmental risks on vascular disease.  Other interests have spanned the fields of personalized medicine and disparities in cardiovascular diseases.  During his academic career, Dr. Quyyumi has carried out more than 50 NIH, industry-funded, or investigator-initiated projects, including numerous clinical trials. Dr. Quyyumi is currently a tenured Professor of Medicine in the Division of Cardiology at Emory University School of Medicine and Co-Director at Emory Clinical Cardiovascular Research Institute. He is Board certified in Internal Medicine and Cardiology, and is a Fellow of the Royal College of Medicine. He graduated from Guy’s Hospital medical school in London, and after accomplishing part of his medicine and cardiology training in London, he completed his fellowship training at Massachusetts general Hospital, Harvard University in Boston and at the National Institutes of Health (NIH), Bethesda, Maryland. He was a Senior Investigator and director of the cardiac catheterization laboratory at the Cardiology Branch of the National Institutes of Health for several years before arriving at Emory. His research focus over the last quarter century has been on clinical and translational research in vascular biology, progenitor cells and angiogenesis, biomarkers and cardiovascular genomics. He has performed seminal studies investigating mechanisms of myocardial ischemia including silent ischemia in the past. His current studies include comprehensive assessment of vascular endothelial function and arterial stiffness and thickness in patients with arteriosclerosis and its risk factors. Other studies investigate the role of genetic and environmental risks on vascular disease, and particularly in relation to health disparities. He is also conducting clinical trials with bone marrow derived stem cells and progenitors in cardiovascular disease. He has published over 250 manuscripts in peer-reviewed journals. Dr. Arshed A. Quyyumi has been involved in clinical translational research in cardiovascular diseases for over 25 years.  Dr. Quyyumi received his undergraduate degree in Pharmacology and medical degree  from the University of London, England. He completed his residency at Guy's and Royal Free Hospitals in London, and cardiology fellowships at National Heart Hospital, London; Massachusetts General Hospital, Boston; and the National Institutes of Health.   After completion of his residency and fellowship, he served in several capacities in the Cardiology Branch of National Heart Lung and Blood Institute, NIH in Bethesda, MD, including Senior Investigator and Director of the Cardiac Catheterization Laboratory.  In 2001 he was appointed Professor of Medicine in the Division of Cardiology at Emory University School of Medicine, and in 2010 he was named Co-Director of the Emory Clinical Cardiovascular Research Institute (ECCRI).  Since 2005, Dr. Quyyumi has been awarded more than $21 million in research funding.  He serves on the Editorial Boards of several national journals, is a member on several Scientific Advisory Boards, and is a reviewer for the NIH-NHLBI Study Sections.  Dr. Quyyumi has authored more than 180 peer-reviewed publications and has been an invited speaker and session chair at numerous National and International scientific meetings and conferences. Dr. Quyyumi's research focus includes vascular biology, angiogenesis, progenitor cell biology, mechanisms of myocardial ischemia, and the role of genetic and environmental risks on vascular disease.  Other interests have spanned the fields of personalized medicine and disparities in cardiovascular diseases.  During his academic career, Dr. Quyyumi has carried out more than 50 NIH, industry-funded, or investigator-initiated projects, including numerous clinical trials. Dr. Quyyumi is currently a tenured Professor of Medicine in the Division of Cardiology at Emory University School of Medicine and Co-Director at Emory Clinical Cardiovascular Research Institute. He is Board certified in Internal Medicine and Cardiology, and is a Fellow of the Royal College of Medicine. He graduated from Guy’s Hospital medical school in London, and after accomplishing part of his medicine and cardiology training in London, he completed his fellowship training at Massachusetts general Hospital, Harvard University in Boston and at the National Institutes of Health (NIH), Bethesda, Maryland. He was a Senior Investigator and director of the cardiac catheterization laboratory at the Cardiology Branch of the National Institutes of Health for several years before arriving at Emory. His research focus over the last quarter century has been on clinical and translational research in vascular biology, progenitor cells and angiogenesis, biomarkers and cardiovascular genomics. He has performed seminal studies investigating mechanisms of myocardial ischemia including silent ischemia in the past. His current studies include comprehensive assessment of vascular endothelial function and arterial stiffness and thickness in patients with arteriosclerosis and its risk factors. Other studies investigate the role of genetic and environmental risks on vascular disease, and particularly in relation to health disparities. He is also conducting clinical trials with bone marrow derived stem cells and progenitors in cardiovascular disease. He has published over 250 manuscripts in peer-reviewed journals.

Research Interest

Dr. Quyyumi's research focus includes vascular biology, angiogenesis, progenitor cell biology, mechanisms of myocardial ischemia, and the role of genetic and environmental risks on vascular disease.  Other interests have spanned the fields of personalized medicine and disparities in cardiovascular diseases.  During his academic career, Dr. Quyyumi has carried out more than 50 NIH, industry-funded, or investigator-initiated projects, including numerous clinical trials.